»á̾:KouNAKAMURA ¤Î¸¡º÷·ë²Ì / 1 1 - 2 / 2 <<< 1 >>> / 1 1 - 2 / 2 <<< 1 >>> 4B024 2025/03/07 14:15 ¥Ý¥¹¥¿¡¼¡¦Å¸¼¨²ñ¾ì ưʪͳÍè´õ¾¯ÊüÀþ¶Ý¤«¤é¤Î¹³ÀþÃî³èÀ¤ò¼¨¤¹À¸Íý³èÀʪ¼Á¤Î²òÀÏ Analysis of bioactive compounds exhibiting antinematode from animal-derived rare¡¡actinomycetes. ¡ûÌÏÁÇ ´õ1¡¢¾¾Èø º»µª1¡¢Ãæ¼ Þ«1¡¢É÷´Ö ·¼1¡¢²Ãúó ¤Á¤Ò¤í1¡¢Á긶 ¾°Ç·1¡¢ÊÒÊ¿ ¹À¹§2¡¢Æ⻳ ½ßÊ¿3¡¢Æó¼ ͧ»Ë4¡¢»æÆ© ¿¼£1 ¡ûNozomi MOSU1, Saki MATSUO1, Kou NAKAMURA1, Kei KAZAMA1, Chihiro KASE1, Naoyuki AIHARA1, Hirotaka KATAHIRA2, Jumpei UCHIYAMA3, Yushi FUTAMURA4, Shinji KAMISUKI1 1ËãÉÛÂç½Ã°å¡¢2ËãÉÛÂçÀ¸Ì¿´Ä¶²Ê³Ø¡¢3²¬»³Âç¡¢4Íý¸¦CSRS 1The Univ. of Azabu, 2The Univ. of Azabu environment, 3The Univ. of Okayama, 4RIKEN CSRS 4B039 2025/03/07 13:15 ¥Ý¥¹¥¿¡¼¡¦Å¸¼¨²ñ¾ì ³ËÆâ¼õÍÆÂÎNR4A1¥ê¥¬¥ó¥É¤Îõº÷¤È¹³¥¦¥¤¥ë¥¹³èÀ Exploration of nuclear receptor NR4A1 ligands and their antiviral activities ¡û´Ý»³ ²Úô¥1¡¢Ãæ¼ Þ«1¡¢Â綶 ·¼»Ë2,3¡¢ÃæÅè ¾Ï¸ç1,2,3¡¢»³Æâ ⫵©1¡¢ÌÏÁÇ ´õ1¡¢Â¼¾å ͵¿®1¡¢²¬ÅÄ Ëã°á»Ò5¡¢ÁÒ»ý ¹¬»Ê4¡¢ÅϻΠ¹¬°ì2,3,4¡¢»æÆ© ¿¼£1 ¡ûKarin MARUYAMA1, Kou NAKAMURA1, Hirofumi OHASHI2,3, Shogo NAKAJIMA1,2,3, Koki YAMAUCHI1, Nozomi MOSU1, Hironobu MURAKAMI1, Maiko OKADA5, Kouji KURAMOCHI4, Koichi WATASHI2,3,4, Shinji KAMISUKI1 1ËãÉÛÂç½Ã°å¡¢2´¶À÷¸¦¡¦¼£ÎÅÌô¡¦¥ï¥¯¥Á¥ó³«È¯¸¦µæ¥»¥ó¥¿¡¼¡¢3´¶À÷¸¦¡¦¥¦¥¤¥ë¥¹ÂèÆóÉô¡¢4ÅìÍýÂçÁÏ°èÍý¹©¡¢5Åìµþ¹©²ÊÂç±þÍÑÀ¸Êª 1School of Veterinary Medicine, Azabu Univ., 2Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, 3Department of Virology II, National Institute of Infectious Diseases, 4Tokyo Univ. of Science, 5Tokyo Univ. of Technology / 1 1 - 2 / 2 <<< 1 >>> / 1 1 - 2 / 2 <<< 1 >>>